Il Dong Pharmaceutical Co Ltd Cash Flow Conversion Efficiency
Il Dong Pharmaceutical Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Il Dong Pharmaceutical Co Ltd (249420) has a cash flow conversion efficiency ratio of 0.050x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩11.28 Billion ≈ $7.65 Million USD) by net assets (₩226.84 Billion ≈ $153.72 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Il Dong Pharmaceutical Co Ltd (2016–2024)
Cash flow conversion efficiency of Il Dong Pharmaceutical Co Ltd from 2016 to 2024. This chart illustrates how Il Dong Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 249420 stock price for real-time trading data and today's change.
Il Dong Pharmaceutical Co Ltd Cash Flow Conversion Ratio Explained
Il Dong Pharmaceutical Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Il Dong Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Il Dong Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Also see Il Dong Pharmaceutical Co Ltd (249420) market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Anika Therapeutics Inc
NASDAQ:ANIK
|
-0.005x |
|
DYNAM JAPAN HOLDINGS Co. Ltd
F:2DJ
|
0.102x |
|
Columbus Circle Capital Corp I Class A Ordinary Shares
NASDAQ:CCCM
|
-0.002x |
|
Mahamaya Steel Industries Limited
NSE:MAHASTEEL
|
-0.023x |
|
Zhejiang Dilong New Material Co Ltd
SHE:002247
|
0.021x |
|
Beijing Piesat Information Technology Co Ltd
SHG:688066
|
0.072x |
|
Karmarts Public Company Limited
BK:KAMART
|
0.029x |
|
EnviTec Biogas AG
XETRA:ETG
|
0.086x |
Annual Cash Flow Conversion Efficiency for Il Dong Pharmaceutical Co Ltd (2016–2024)
The table below shows the annual cash flow conversion efficiency of Il Dong Pharmaceutical Co Ltd from 2016 to 2024. Review Il Dong Pharmaceutical Co Ltd free cash flow ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩159.06 Billion ≈ $107.79 Million |
₩28.29 Billion ≈ $19.17 Million |
0.178x | +184.66% |
| 2023-12-31 | ₩174.27 Billion ≈ $118.10 Million |
₩-36.62 Billion ≈ $-24.81 Million |
-0.210x | +22.21% |
| 2022-12-31 | ₩198.22 Billion ≈ $134.33 Million |
₩-53.54 Billion ≈ $-36.28 Million |
-0.270x | -281.61% |
| 2021-12-31 | ₩160.58 Billion ≈ $108.83 Million |
₩-11.37 Billion ≈ $-7.70 Million |
-0.071x | -193.03% |
| 2020-12-31 | ₩254.55 Billion ≈ $172.50 Million |
₩19.37 Billion ≈ $13.12 Million |
0.076x | -53.49% |
| 2019-12-31 | ₩252.89 Billion ≈ $171.38 Million |
₩41.37 Billion ≈ $28.03 Million |
0.164x | -32.06% |
| 2018-12-31 | ₩276.82 Billion ≈ $187.60 Million |
₩66.65 Billion ≈ $45.17 Million |
0.241x | -6.91% |
| 2017-12-31 | ₩285.07 Billion ≈ $193.19 Million |
₩73.72 Billion ≈ $49.96 Million |
0.259x | +50.98% |
| 2016-12-31 | ₩268.41 Billion ≈ $181.90 Million |
₩45.98 Billion ≈ $31.16 Million |
0.171x | -- |
About Il Dong Pharmaceutical Co Ltd
Ildong Pharmaceutical Co., Ltd. develops, manufactures, and sells pharmaceutical products in South Korea. The company offers active lactic acid bacterial and anti-diarrheal agents, antibiotics, antifungal and antiviral products, anti-cancer, antineoplastic agents, and NSAIDs and analgesics, as well as vitamins, minerals, and nutrients; and drugs for blood circulation, cardiovascular and central n… Read more